Yale Study Finds Most Telehealth GLP-1 Vendors Skip Live Clinician Visits
A secret shopper study published July 6 in JAMA found that most telehealth platforms prescribing GLP-1 medications do not require real-time clinician interaction with patients before prescribing. Yale researchers documented prescribing practices across online vendors selling these weight-loss and diabetes medications. The study raises questions about appropriateness of care, patient safety, and adherence to clinical practice standards in the rapidly growing direct-to-consumer telehealth market for high-cost specialty drugs. Implications for Medicaid managed care organizations include potential utilization management concerns and pharmacy benefit oversight challenges.
MCOs covering GLP-1s through pharmacy or medical benefits may face utilization and safety concerns if members access prescriptions through telehealth vendors that bypass standard clinical evaluation protocols.
Pharmacy · Managed Care
You might also like